Last update:

Gastroenterology news

Experimental mRNA therapy dramatically extends treatment window for acetaminophen overdose in preclinical models

When a patient arrives at the hospital with an acetaminophen overdose, it's often a race against the clock. The only FDA-approved antidote for overdose-related liver injury, N‑acetylcysteine, must be administered within hours ...

Stomach bacterium hijacks healing signals to drive precancerous changes, study finds

Stomach cancer is one of the deadliest forms of cancer. Unlike many other types of cancer, however, one of its main causes is well known: chronic infection with the bacterium Helicobacter pylori. A team headed by Charité—Universitätsmedizin ...

Gut microbiome can reveal risk of type 2 diabetes

Changes in the composition of gut bacteria could provide an early warning of type 2 diabetes (T2D), according to new research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) ...

Probiotics linked to fewer deaths in premature babies

Probiotic supplementation in very preterm babies was linked to a lower risk of both severe intestinal disease and death. This is shown by a new study from the Karolinska Institutet, published in JAMA Network Open. The findings ...

B cells may help predict risk of colitis from immunotherapy

Researchers at The University of Texas MD Anderson Cancer Center have identified a previously unknown role for B cells, adaptive immune cells, in triggering and sustaining colitis as a side effect of immune checkpoint inhibitors, ...

New global research highlights burden of unsafe food

If it isn't safe, it isn't food. That message sits at the heart of a major new global effort by the World Health Organization (WHO). University of Waterloo public health researcher Dr. Shannon Majowicz contributed research ...

Colon cancer cells may change identity to metastasize

Loss of GATA6—a transcription factor that controls which genes are turned on or off—can reprogram colorectal cancer cells into more primitive, adaptable states that can then spread to the liver and establish new tumors, according ...

Engineered probiotic heads to human trials

A probiotic bioengineered by UBC Okanagan researchers to thrive in the inflamed gut is set to enter human clinical trials in Australia this summer, capping a decade-long effort to turn a beneficial bacterium into a treatment ...

Microplastics may worsen fatty liver disease, new study suggests

Microplastics—minuscule pieces of plastic broken down from larger plastic waste—are a growing concern for human health, especially for the liver. A study from the University of Oklahoma, published in Science Advances, demonstrates ...